Inflammatory Bowel Disease

Show Only Open Trials
1.

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

  • Study Status: Open to Enrollment
  • Sponsor: Elan Pharmaceuticals
  • Disease Status and/or Stage: Crohn's Disease Being Treated with TYSABRI
2.

The Multi-Center African American IBD Study (MAAIS)

  • Study Status: Open to Enrollment
  • Sponsor: National Institutes of Digestive Diseases and Kidney (NIDDK)
  • Disease Status and/or Stage: African-Americans with IBD, a Family Member with IBD, or Healthy Volunteers

Top of page